May 06, 2021
By Jane Brown
The co-chair of Canada’s vaccine advisory committee says anyone who took the AstraZeneca COVID-19 vaccine did the right thing and should not feel they got a second best vaccine.
Dr. Caroline Quach, co-chair of NACI, released a statement late Wednesday night, clarifying comments she made earlier in the week that the preferred vaccines for low risk individuals are Pfizer and Moderna.
When NACI released its recommendation on the Johnson & Johnson vaccine, the advisory committee said Canadians who can wait for an mRNA vaccine, like Pfizer or Moderna, should do so, rather than taking a viral-vector type vaccine like Johnson & Johnson, or AstraZeneca.
Quach says she was not trying to suggest the AstraZeneca vaccine, which over one million Canadians have already received, was a second-best choice.
Quach says people who received the AZ vaccine did the right thing by protecting themselves and their families against COVID 19.
Both the AstraZeneca and Johnson & Johnson vaccines come with an extremely rare risk of blood clots. The risk of a new type of thrombosis is considered to be 1 in 100,000 to 250,000 administered doses.